Texas data center registration coincides with Core Scientific stock upward price move

Texas data center registration coincides with Core Scientific stock upward price move
Core Scientific rises 4.92% to $14.18

Core Scientific (CORZ) stock is trading at $14.18 after a 4.92% rise for the day. The price currently sits above its key short- and medium-term moving averages but remains below the longer-term benchmark average.

CORZ price prediction
24H 0.07%
$14.06
48H 1.85%
$14.31
7D 1.28%
$14.23
1M -5.27%
$13.31
3M -33.81%
$9.3
6M -36.65%
$8.9
12M -32.24%
$9.52
Current price: $14.05 0.5500 4.07%
Closed 11/18
Daily range 13.43 Arrow from to Icon 14.24
Weekly range 13.09 Arrow from to Icon 14.78
Loading...

Highlights

  • Core Scientific approved a $1.3 billion Texas data center build, showing a major shift into AI hosting infrastructure.
  • The expansion targets higher-margin, technology-focused services to capture increasing institutional and client demand for AI hosting.
  • Shares of Core Scientific rose 4.92% to $14.18, facing mixed technical momentum with price action expected between $13.42 and $14.94 in the next few days.

AI infrastructure pivot boosts capital flows and growth expectations

Core Scientific's recent $1.3 billion data center construction project in Texas, filed by its subsidiary Telios Quinlan One LLC, represents a significant capital commitment and underlines the company's strategic transition into AI hosting, according to Chaincatcher. This scale of investment directly signals an expansion into higher-margin, technology-driven markets, increasing institutional and client demand for Core Scientific's capabilities. As the company pivots toward AI infrastructure, the market is recognizing the potential for enhanced revenue generation and operational scalability.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Mixed momentum signals persist as price tests major technical barriers

On the technical front, CORZ is trading above the H1 SMA-20 at $13.74 and the H1 SMA-50 at $13.66, but remains below the D1 SMA-200 at $19.33. Immediate support is provided by the Ichimoku Kijun at $13.86. MACD delivers a strong sell signal while ADX, RSI, CCI, and Awesome Oscillator are all neutral. Stoch RSI is in the overbought zone, indicating a potential short-term pullback, though Bull/Bear Power remains positive at 0.37, reflecting moderate intraday buyer strength.

Upside bias holds as consolidation defines near-term risk

Over the next 2–3 trading days, CORZ is expected to consolidate within the $13.42–$14.94 volatility band relative to current levels. Probability favors an upside move at 79%, while a downside break has a 21% chance of occurring. The baseline scenario anticipates sideways price action within these bounds, with a bullish extension likely if resistance is breached or a bearish move possible if support fails.

Anton Kharitonov, Traders Union expert, sees Core Scientific benefiting from its decisive $1.3 billion investment in AI infrastructure, but remains skeptical given mixed technical signals. The price is currently above the H1 SMA-20 at $13.74 and H1 SMA-50 at $13.66, while still trading below the D1 SMA-200 at $19.33. With MACD giving a strong sell and the Stoch RSI overbought, the setup suggests potential short-term pullback is likely, despite a generally positive longer-term outlook. "Base case remains consolidation—if support at $13.42 fails, I expect further downside despite recent news-driven optimism."

Earlier, analysts noted that Core Scientific demonstrated mixed technical momentum and was consolidating as it awaited a decisive breakout, amid a positive outlook for AI-related growth. The latest analysis confirms this evolving transition, with increased institutional interest and a new volatility band suggesting that traders should closely monitor $14.94 as a key resistance level for a potential bullish extension.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.